Pulse Explorar nav.journalClub Debates Tendências Pesquisadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

Treatment of Myelodysplastic Syndromes with AML-Type Chemotherapy | Synapse

January 1, 1993

Treatment of Myelodysplastic Syndromes with AML-Type Chemotherapy

Key Points

Key points are not available for this paper at this time.

Abstract

Click to increase image sizeClick to decrease image sizeKey Words: Myelodysplastic syndromesAMLchemotherapypre-leukemiasmoldering leukemia

Perguntar à IA

Like

Bookmark

Share

Perguntar à IA

Like

Bookmark

Share

Cite This Study

Estey et al. (Fri,) studied this question.

synapsesocial.com/papers/6a154135cb801b7f954e465b https://doi.org/https://doi.org/10.3109/10428199309064263

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy2008 · 136 citations
2Effect of chemotherapy for the dysmyelopoietic syndrome.1981 · 110 citations
3Proposals for the classification of the myelodysplastic syndromes1982 · 3,665 citations
4Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.1987 · 37 citations
5Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.1988 · 218 citations